Lv01
0 积分 2025-02-08 加入
Prostate cancer immunotherapy
1小时前
待确认
B7-1 and GM-CSF enhance the anti-tumor immune effect of DC-tumor fusion vaccine in the treatment of prostate cancer
1小时前
待确认
Immunotherapy for Non-Muscle-Invasive Bladder Cancer: from the Origins of BCG to Novel Therapies
2小时前
已完结
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial
2小时前
已完结
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial
2小时前
已完结
皖公网安备34019202002308
